XGN
Exagen Inc
8.70$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -208.3% | – | – | – | -3,039.7% | – | – | -202.3% | – | – | – | |
| – | -16.2% | -9.7% | -6.3% | -1.6% | -1.7% | +6.0% | +5.9% | +31.3% | -2.0% | -0.2% | +4.8% | – | |
| – | -14.3% | -27.5% | +1.3% | -61.3% | +99.5% | -3.7% | +6.2% | +33.9% | +18.9% | -7.1% | +49.6% | – | |
| – | +1,771.6% | -164.8% | – | – | +55.6% | -376.8% | – | – | -78.2% | -698.4% | – | – | |
| – | +5,200.0% | -18.9% | +58.1% | +8.1% | -0.7% | -22.6% | +85.0% | +31.6% | -84.0% | +418.2% | +138.2% | – | |
| – | +4,100.0% | +2.4% | +58.1% | +8.1% | -0.7% | -26.7% | +95.3% | +31.6% | -87.3% | +551.4% | +138.2% | – | |
| – | – | -18.1% | – | – | – | – | -99.5% | +19,800.0% | – | – | – | – | |
| – | – | – | – | – | +0.5% | -8.8% | – | -108.9% | +3.0% | +3.2% | +3.6% | – | |
| – | +103.7% | -54.5% | +126.0% | -46.5% | +78.5% | -70.4% | – | -86.5% | -113.0% | -83.9% | +496.8% | – | |
| – | – | -214.7% | – | – | – | -1,084,300.0% | – | -70.2% | -161.1% | – | – | – | |
| – | – | -210.7% | – | – | – | -5,069.6% | – | – | -214.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.